| Ariel Schwartz, OTR/L | |
|
19 Granville Rd, Cambridge, MA 02138-6806 | |
| (703) 795-0459 | |
| Not Available |
| Full Name | Ariel Schwartz |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 19 Granville Rd, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154777852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 11907 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ariel Schwartz, OTR/L 19 Granville Rd, Cambridge, MA 02138-6806 Ph: () - | Ariel Schwartz, OTR/L 19 Granville Rd, Cambridge, MA 02138-6806 Ph: (703) 795-0459 |
News Archive
A Michigan State University surgeon is teaming up with a Lansing-area dental benefits firm on a clinical trial to create a simple, cost-effective saliva test to detect oral cancer, a breakthrough that would drastically improve screening and result in fewer people dying of the world's sixth most common cancer.
Cell Therapeutics, Inc. announced today that CTI's Marketing Authorization Application seeking approval for Pixuvri (pixantrone dimaleate) for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's lymphoma was validated and accepted for review by the European Medicines Agency.
A small cadre of lawyers, some from out of state, are using New York City's age and architectural quirkiness as the foundation for a flood of lawsuits citing violations of the Americans With Disabilities Act. The lawyers are generally not acting on existing complaints from people with disabilities.
Boosting the blood count – in effect, curing anemia – in conjunction with radiation therapy won't help patients with head and neck cancer fare any better than with radiation alone, says a national study led by Jefferson Medical College researchers.
Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced it has initiated ALX148 combination dosing with targeted antibody therapies in its Phase 1 clinical program in patients with advanced solid tumors and lymphoma.
› Verified 9 days ago
Rachelle Dickinson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 | |
Danielle Ferris, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 | |
Linda Gorman Vena, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 163 Gore St, Cambridge, MA 02141 Phone: 617-665-3000 | |
Mrs. Erin Elizabeth Holyoke, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 799 Concord Ave, Cambridge, MA 02138 Phone: 617-868-2200 | |
Claire Marie Heinegg, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge Health Alliance, Cambridge, MA 02139 Phone: 617-591-4531 | |
Amy Elizabeth Tashjian, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 978-852-9173 | |
Jocelyn Rogers, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 |